Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Grifols SA - ADR - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
GRFS
Nasdaq
2836
https://www.grifols.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Grifols SA - ADR
Are Investors Undervaluing Grifols (GRFS) Right Now?
- Mar 15th, 2023 1:40 pm
Grifols (GRFS) Upgraded to Strong Buy: Here's Why
- Mar 7th, 2023 5:00 pm
Selagine Enters into a Collaborative Agreement with Grifols for Development and Commercialization of Immunoglobulin Eye Drops for Treating Dry Eye Disease
- Mar 6th, 2023 12:00 pm
UPDATE 2-Grifols' shares tank 10% as 2023 outlook disappoints
- Feb 28th, 2023 8:23 am
Is Grifols (GRFS) Stock Undervalued Right Now?
- Feb 27th, 2023 2:40 pm
Spanish drug company with Bay Area operations to shed 2,300 jobs
- Feb 17th, 2023 10:07 pm
Grifols to lay off 8.5% of workforce under $427 mln savings plan
- Feb 15th, 2023 5:22 pm
Is Grifols (GRFS) a Great Value Stock Right Now?
- Feb 10th, 2023 2:40 pm
Grifols considers selling 2 bln euros worth of assets to cut debt, Cinco Dias says
- Dec 14th, 2022 9:00 am
Grifols receives FDA clearance for AlphaID™ At Home, the first free service for U.S. consumers to determine their risk for alpha-1
- Nov 3rd, 2022 1:00 pm
10Â Best Pharma Stocks To Buy Now
- Oct 24th, 2022 2:13 pm
Grifols says U.S. blood donors' lawsuit won't have material impact, shares down
- Oct 21st, 2022 12:09 pm
10 Best Low Price Pharma Stocks To Buy Now
- Oct 18th, 2022 1:03 pm
Grifols appoints executive chairman as seeks to speed recovery
- Oct 3rd, 2022 6:05 pm
Victor Grifols Roura decides to retire as Chairperson; Grifols appoints private equity veteran Steven F. Mayer as Executive Chairperson
- Oct 3rd, 2022 4:52 pm
GigaGen Awarded Contract by U.S. Department of Defense to Discover Synthetic Human Antibody Treatments for High-Priority Toxins and Pathogens
- Sep 15th, 2022 2:29 pm
Grifols enters into agreement with Canadian Blood Services to accelerate self-sufficiency in immunoglobulins for Canada
- Sep 7th, 2022 4:06 pm
10 Best Medical Stocks Under $10
- Aug 6th, 2022 12:10 pm
Grifols Procleix Plasmodium Assay receives CE mark, a first for malaria blood screening
- Jun 8th, 2022 9:00 am
Got $20? These 3 Healthcare Stocks Could Be Bargain Buys for 2022 and Beyond
- May 26th, 2022 12:05 pm
Scroll